Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Canopy Growth CorporationTSX: WEED.TO

Income Tax Expense · Q4 FY2025 · quarter ended Mar 2026

Income tax expense turns negative

Q4 FY2025 income tax expense was -CA$934.47K, compared with CA$329K a year earlier. Trailing-twelve-month income tax expense was CA$23K.

Context

  • Income tax expense amounted to 0.0% of revenue in FY2025, down 2.6 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near -CA$934.47K or moves back toward the trailing-twelve-month quarterly average of CA$5.75K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$934.47K-353.9% QoQ
Last fiscal yearMar 2026
CA$23K-99.7% YoY
LTMMar 2026
CA$23K-99.7% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-384.0%——
1 year-99.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

CAD · from the income statement

Latest · FY2025
23K CAD
Year-over-year change
-99.7%

Income Tax Expense vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -99.7% is the 4th highest of 7, against a peer median of -73.0%.
  • Income tax expense amounts to 0.0% of revenue for WEED.TO, versus a peer median of 1.0%.
WEED.TO Competitors
Income Tax Expense for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$29.02M USD+30.6%—11.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$23K CAD-99.7%—0.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%-10.3%0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026-CA$1.21M CAD+85.1%—0.8%
ACB.TOAurora Cannabis Inc.LTM Mar 2026-CA$3.25M CAD-170.4%—1.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026-$10.76M USD-45.9%—21.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$13.66M CAD-17878.9%—5.0%
Peer median (excluding WEED.TO) —-73.0%-10.3%1.0%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M284.6M
Cost of Revenue653.93M431.64M216.26M189.48M214.93M
Gross Profit(143.6M)(98.38M)80.88M79.51M69.67M
Gross Margin-30.2%-29.5%27.2%29.6%24.5%
Research & Development32.26M21.72M4.61M2.74M0
Selling, General & Admin361.1M297.98M175.98M121.71M122.93M
Operating Expenses445.08M297.4M309.6M196.65M142.78M
Depreciation & Amortization110.94M80.03M53.18M43.12M36.47M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)(188.22M)
EBITDA Margin-11.1%-864.2%-105.3%-178.2%-66.1%
Operating Income(588.69M)(395.78M)(228.71M)(117.14M)(73.11M)
Operating Margin-123.8%-118.8%-77.0%-43.5%-25.7%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses370.63M(2.69B)(242.64M)(479.85M)(189.78M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-92.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(262.91M)
Net Margin-65.2%-983.7%-221.2%-222.4%-92.4%
EPS (Basic)(0.81)(12.18)(8.79)(5.56)(0.76)
EPS (Diluted)(0.81)(12.18)(8.79)(5.56)(0.76)
Weighted Avg Shares396.1M271.61M74.79M107.55M345.53M
Weighted Avg Shares (Diluted)396.36M271.61M74.79M107.55M345.53M

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.